The factors that reduced the probability of procedure-related mortality in both men and women were TIMI flow grade, the use of P2Y12 inhibitors in the peri-infarct period, and arterial hypertension (Figure 2 and Figure 3). This evidence concerns the gene P2RY12 and Hypertension.